Literature DB >> 15222029

Angiogenesis in rabbit hepatic tumor after transcatheter arterial embolization.

Xiao-Feng Liao1, Ji-Lin Yi, Xing-Rui Li, Wei Deng, Zhi-Fang Yang, Geng Tian.   

Abstract

AIM: To investigate the effect of transcatheter arterial embolization (TAE) on angiogenesis of hepatic tumor.
METHODS: Twenty New Zealand White rabbits were randomly divided into two groups of 10 each and VX2 carcinoma was implanted in the left medial lobes of the livers. Fourteen days later, a silicon catheter was inserted into the left hepatic artery of rabbit with VX2 hepatic tumor and infusion was performed via the hepatic artery using Lipiodol (the TAE group) or saline (the control group). Rabbits were sacrificed 7 d after treatment and tumor tissues were excised. Expression of vascular endothelial growth factor (VEGF) protein and microvessel density (MVD) of tumors were examined using immunohistochemistry. The staining intensity of VEGF was evaluated with a computer-assisted image-analyzer. Reverse transcription-polymerase chain reaction (RT-PCR) was used to detect the VEGF mRNA expression of tumors.
RESULTS: MVD was higher in the TAE group compared with the control group (28.6+/-10.6 vs 16.3+/-6.9, P<0.01). Expression of VEGF protein was enhanced after TAE. The staining intensity of VEGF in the TAE group was 0.162+/-0.018, significantly higher than in the control group (0.142+/-0.01, P<0.01). At mRNA level, VEGF165 mRNA was significantly higher in the TAE group compared with the control group (2.58+/-0.42 vs 1.99+/-0.21, P<0.001). MVD was well correlated to VEGF expression in both the TAE group (r=0.69, P<0.05) and the control group (r=0.72, P<0.05).
CONCLUSION: TAE promotes the development of neovascularization of residual tumors through up-regulation of VEGF expression, possibly due to hypoxic insult.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15222029      PMCID: PMC4572223          DOI: 10.3748/wjg.v10.i13.1885

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  45 in total

1.  Expression of platelet-derived endothelial cell growth factor and vascular endothelial growth factor in hepatocellular carcinoma and portal vein tumor thrombus.

Authors:  J Zhou; Z Y Tang; J Fan; Z Q Wu; X M Li; Y K Liu; F Liu; H C Sun; S L Ye
Journal:  J Cancer Res Clin Oncol       Date:  2000-01       Impact factor: 4.553

2.  Tumor microvessel density as a predictor of recurrence after resection of hepatocellular carcinoma: a prospective study.

Authors:  Ronnie Tung-Ping Poon; Irene Oi-Lin Ng; Cecilia Lau; Wun-Ching Yu; Zhen-Fan Yang; Sheung-Tat Fan; John Wong
Journal:  J Clin Oncol       Date:  2002-04-01       Impact factor: 44.544

3.  Synergistic effect of basic fibroblast growth factor and vascular endothelial growth factor in murine hepatocellular carcinoma.

Authors:  Hitoshi Yoshiji; Shigeki Kuriyama; Junichi Yoshii; Yasuhide Ikenaka; Ryuichi Noguchi; Daniel J Hicklin; James Huber; Toshiya Nakatani; Hirohisa Tsujinoue; Koji Yanase; Hiroo Imazu; Hiroshi Fukui
Journal:  Hepatology       Date:  2002-04       Impact factor: 17.425

4.  Microvessel density of hepatocellular carcinoma: its relationship with prognosis.

Authors:  H C Sun; Z Y Tang; X M Li; Y N Zhou; B R Sun; Z C Ma
Journal:  J Cancer Res Clin Oncol       Date:  1999-07       Impact factor: 4.553

5.  Rapid progression of hepatocellular carcinoma after transcatheter arterial chemoembolization and percutaneous radiofrequency ablation in the primary tumour region.

Authors:  T Seki; T Tamai; K Ikeda; M Imamura; A Nishimura; N Yamashiki; T Nakagawa; K Inoue
Journal:  Eur J Gastroenterol Hepatol       Date:  2001-03       Impact factor: 2.566

6.  Differential expression of VEGF mRNA splice variants in newborn and adult hyperoxic lung injury.

Authors:  R H Watkins; C T D'Angio; R M Ryan; A Patel; W M Maniscalco
Journal:  Am J Physiol       Date:  1999-05

7.  Treatment of hypervascular small hepatocellular carcinoma with ultrasound-guided percutaneous acetic acid injection: comparison with segmental transcatheter arterial embolization.

Authors:  K Ohnishi; H Yoshioka; K Kosaka; K Toshima; J Nishiyama; C Kameda; S Ito; K Fujiwara
Journal:  Am J Gastroenterol       Date:  1996-12       Impact factor: 10.864

8.  Effects of preoperative transcatheter hepatic arterial chemoembolization for hepatocellular carcinoma. The relationship between postoperative course and tumor necrosis.

Authors:  E Adachi; T Matsumata; T Nishizaki; H Hashimoto; M Tsuneyoshi; K Sugimachi
Journal:  Cancer       Date:  1993-12-15       Impact factor: 6.860

9.  Increased expression of vascular endothelial growth factor is associated with tumor progression in hepatocellular carcinoma.

Authors:  T Torimura; M Sata; T Ueno; M Kin; R Tsuji; K Suzaku; O Hashimoto; H Sugawara; K Tanikawa
Journal:  Hum Pathol       Date:  1998-09       Impact factor: 3.466

10.  Microvessel density, a surrogate marker of angiogenesis, is significantly related to survival in multiple myeloma patients.

Authors:  Giancarlo Pruneri; Maurilio Ponzoni; Andrés J M Ferreri; Nicola Decarli; Moreno Tresoldi; Francesca Raggi; Chiara Baldessari; Massimo Freschi; Luca Baldini; Maria Goldaniga; Antonino Neri; Nadia Carboni; Francesco Bertolini; Giuseppe Viale
Journal:  Br J Haematol       Date:  2002-09       Impact factor: 6.998

View more
  9 in total

1.  Value of the portal venous phase in evaluation of treated hepatocellular carcinoma following transcatheter arterial chemoembolisation.

Authors:  A Lam; D Fernando; C C Sirlin; M Nayyar; S C Goodwin; D K Imagawa; C Lall
Journal:  Clin Radiol       Date:  2017-08-02       Impact factor: 2.350

2.  Pickering-Emulsion for Liver Trans-Arterial Chemo-Embolization with Oxaliplatin.

Authors:  Frederic Deschamps; Kathleen R Harris; Laurence Moine; Weiguo Li; Lambros Tselikas; Thomas Isoardo; Robert J Lewandowski; Angelo Paci; Nicolas Huang; Thierry de Baere; Riad Salem; Andrew C Larson
Journal:  Cardiovasc Intervent Radiol       Date:  2018-02-21       Impact factor: 2.740

3.  Increase of angiogenic growth factors after hepatic artery embolization in patients with neuroendocrine tumours.

Authors:  Catharina M Korse; Johannes M G Bonfrer; Warner Prevoo; Paul Baas; Babs G Taal
Journal:  Tumour Biol       Date:  2011-03-05

4.  Effect of Jianweiyuyang granule on gastric ulcer recurrence and expression of VEGF mRNA in the healing process of gastric ulcer in rats.

Authors:  Xing-Ping Dai; Jia-Bang Li; Zhao-Qian Liu; Xiang Ding; Cheng-Hui Huang; Bing Zhou
Journal:  World J Gastroenterol       Date:  2005-09-21       Impact factor: 5.742

Review 5.  Rabbit VX2 Liver Tumor Model: A Review of Clinical, Biology, Histology, and Tumor Microenvironment Characteristics.

Authors:  Florentina Pascale; Jean-Pierre Pelage; Michel Wassef; Saïda H Ghegediban; Jean-Pierre Saint-Maurice; Thierry De Baere; Alban Denys; Rafael Duran; Frédéric Deschamps; Olivier Pellerin; Noboru Maeda; Alexandre Laurent; Julien Namur
Journal:  Front Oncol       Date:  2022-05-10       Impact factor: 5.738

6.  Preclinical Benefit of Hypoxia-Activated Intra-arterial Therapy with Evofosfamide in Liver Cancer.

Authors:  Rafael Duran; Sahar Mirpour; Vasily Pekurovsky; Shanmugasundaram Ganapathy-Kanniappan; Cory F Brayton; Toby C Cornish; Boris Gorodetski; Juvenal Reyes; Julius Chapiro; Rüdiger E Schernthaner; Constantine Frangakis; MingDe Lin; Jessica D Sun; Charles P Hart; Jean-François Geschwind
Journal:  Clin Cancer Res       Date:  2016-07-20       Impact factor: 12.531

7.  Contrast-enhanced ultrasound after devascularisation of neuroendocrine liver metastases: functional and morphological evaluation.

Authors:  Aymeric Guibal; Thibaud Lefort; Laurence Chardon; Noura Benslama; Sébastien Mulé; Franck Pilleul; Catherine Lombard-Bohas; Lori Bridal; Jean Alain Chayvialle; Olivier Lucidarme; Alban Denys; Thomas Walter
Journal:  Eur Radiol       Date:  2012-09-22       Impact factor: 5.315

8.  Comparison of hypoxia-inducible factor-1alpha expression before and after transcatheter arterial embolization in rabbit VX2 liver tumors.

Authors:  Sumeet Virmani; Thomas K Rhee; Robert K Ryu; Kent T Sato; Robert J Lewandowski; Mary F Mulcahy; Laura M Kulik; Barbara Szolc-Kowalska; Gayle E Woloschak; Guang-Yu Yang; Riad Salem; Andrew C Larson; Reed A Omary
Journal:  J Vasc Interv Radiol       Date:  2008-10       Impact factor: 3.464

Review 9.  Newer treatments for advanced hepatocellular carcinoma.

Authors:  Myeong Jun Song; Si Hyun Bae
Journal:  Korean J Intern Med       Date:  2014-02-27       Impact factor: 2.884

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.